DURECT (DRRX)
(Delayed Data from NSDQ)
$1.84 USD
-0.04 (-1.87%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $1.83 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, DURECT Corporation has a market cap of $58.05M, which represents its share price of $1.87 multiplied by its outstanding shares number of 31.04M. As a small-cap company, DRRX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DRRX 1.84 -0.04(-1.87%)
Will DRRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DRRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DRRX
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
DRRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates
Stevanato Group (STVN) Meets Q4 Earnings Estimates
Other News for DRRX
12 Health Care Stocks Moving In Tuesday's Intraday Session
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views
Durect (DRRX) Downgraded Following Acquisition Agreement
Durect just downgraded at Northland, here's why
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings